We recently found that a human T-cell leukemia virus type 1-infected cell line, MT-2, could support the replication of hepatitis C virus (HCV) (N. Kato, T. Nakazawa, T. Mizutani, and K. Shimotohno, Biochem. Biophys. Res. Commun. 206:863-869, 1995). In order to develop a culture system in which HCV replicates more efficiently, we examined the efficiency of HCV replication in cloned MT-2 cell lines by the limiting dilution method. Consequently, we obtained five clones in which intracellular positive-stranded HCV RNA could be detected until at least 21 days postinoculation (p.i.), as opposed to 15 days p.i. in uncloned MT-2 cells. MT-2C, one of the five clones which supported HCV replication up to 30 days p.i., was used for further characterization of HCV replication. Semiquantitative analysis of HCV by PCR revealed that RNA synthesis in infected cells increased after inoculation, reached a maximum level at 4 days p.i., and maintained this level until at least 11 days p.i. The 5 untranslated region of negative-stranded HCV RNA was also detected in the infected cells by two different methods with strand specificity. These results suggest that HCV replicated and multiplied in the MT-2C cells. HCV-infected MT-2C cells that were treated with antibiotics, such as G418 and hygromycin B, sustained HCV RNA for a longer period than did untreated cells. We demonstrated inhibitory effects on HCV replication by an antisense oligonucleotide complementary to the HCV core encoding region and by interferon-␣. Furthermore, cell-free viral transmission was demonstrated by this culture system. These results suggest that our cell culture system will be useful for studying the mechanism of HCV replication, for screening antiviral agents, and for developing HCV vaccines.
Throughout the world, hepatitis C virus (HCV) is the major etiologic agent of posttransfusional non-A, non-B hepatitis (1, 20) . HCV is an enveloped virus with a positive, single-stranded RNA genome of about 9.5 kb that encodes a large polyprotein precursor of about 3,000 amino acids (2, 14, 38) . Sequential proteolytic processing of the polyprotein produces functional viral proteins in the order NH 2 -C-E1-E2 (E2-B and E2-A/p7)-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH. The putative core, envelope, and nonstructural proteins are abbreviated C, E, and NS, respectively (6, 9-11, 23-25, 34, 40) . Comparison of amino acid sequences of many HCV isolates revealed the presence of two hypervariable regions, HVR1 and HVR2, in the E2 glycoprotein (8, 17) . HVR1 is a major site for genetic mutations in HCV after the onset of hepatitis, and amino acid substitutions in HVR1 result in escape from recognition by preexisting anti-HVR1 antibodies (16, 19, 33) . On the basis of these results, we proposed that frequent mutations in HVR1 are involved in persistent HCV infection (18) . Testing this possibility required the development of an experimental system that would support HCV infection. A few laboratories have reported experimental HCV replication systems using cultured cells (22, 36, 37, 41) . We previously reported that a human T-cell leukemia virus type 1 (HTLV-1)-infected cell line, MT-2, showed susceptibility to HCV (15) . To better understand such susceptibility, we isolated the MT-2 clones that most efficiently supported HCV replication.
In an earlier work we found that MT-2 is susceptible to HCV infection (15) . We assumed that this was due to the presence of occasional HCV-adapted cells mixed within a population of cells that normally does not support the virus. The MT-2 cells were cultured in RPMI 1640 with 10% fetal bovine serum and cloned by a limiting dilution method. We isolated 23 clones and tested them for sensitivity to HCV infection. The source of HCV inoculum used throughout these experiments was a serum designated 1B-1, which was derived from a voluntary HCV-positive blood donor and contained 10 7 HCV genomes (HCV-Ib genotype) per ml (15) . Approximately 10 6 cloned MT-2 cells were inoculated with 0.2 ml of undiluted serum 1B-1 in 4 ml of medium. Cells were incubated for 15 h at 37ЊC with the inoculum and washed three times with phosphatebuffered saline (PBS); then 4 ml of fresh medium was added. At various times during the culture period, 3 ml of medium was collected and centrifuged to separate the cells and culture medium. RNAs from culture medium and cells were prepared with ISOGEN-LS and ISOGEN extraction kits (Nippon Gene Co., Tokyo, Japan), respectively. One-fifth of the RNA sample was used for reverse transcriptase (RT)-nested PCR, as described previously (17) . Table 1 and Fig. 1 show that, with the exceptions of clones 12, 18, and 21, the cloned MT-2 cells retained intracellular HCV RNA 14 days after treatment with the serum, as did the uncloned MT-2 cells (15) . Clones 3, 5, 13, 24, and 25 (renamed MT-2A, -2B, -2C, -2D, and -2E, respectively) retained intracellular HCV RNA at 21 days postinoculation (p.i.). A possible reason for the difference in response may be that efficiency of HCV replication depends on different expression levels of HTLV-1. However, we could not find a significant correlation between the RNA expression level of HTLV-1 tax and susceptibility to HCV infection in the MT-2 cloned cell lines (data not shown). Unlike the culture supernatant of uncloned MT-2 cells, in which HCV RNA was not detected at 4 days p.i., the aforementioned five clones carried HCV RNA in their medium until at least day 11 (data not shown).
MT-2C, which was one of the cell lines cloned from MT-2 cells, supported HCV replication for up to 30 days p.i. (Fig. 1 ) (26) and was used for further characterization of HCV replication. To monitor replication of HCV in MT-2C cells, we measured HCV RNA semiquantitatively by a conventional PCR method (29) , checking the amplification level of the 5Ј untranslated region (UTR) in every fifth cycle of the second PCR. To obtain a calibration profile of gene amplification, we performed RT-nested PCR with in vitro-synthesized positiveor negative-stranded HCV RNA encoding the 5Ј UTR (7). The resulting pattern showed gradual amplification according to the copy number (10 5 to 10 1 copies) of the initial HCV RNA ( Fig. 2A) . In both strands, the amplified product was detected after 30 cycles of the second PCR from the sample containing 10 copies of HCV RNA; fewer cycles could be applied for detection of more than 10 copies of RNA in the reaction mixture. The amplification pattern was reproducible between experiments and did not change upon the addition of cellular RNA before the reaction. By analyzing the endpoint of detection of the amplified DNA in a set of reaction mixtures with serially diluted RNA at each cycle from 10 to 35 in the second PCR, the amount of HCV RNA in each reaction mixture, ranging from 10 1 to 10 5 , could be estimated. By this method, we quantified HCV RNA in MT-2C cells during the first 11 days following infection. RNA was extracted from HCV-infected cells and the culture medium at 1 to 11 days p.i. and was subjected to RT-nested PCR. The 5Ј UTR of positive-stranded HCV RNA was detected in the cells from 1 to 11 days p.i., but the level of amplification differed between specimens. We determined critical numbers of cycles (10, 15, 20, 25, 30 , or 35 cycles) in second PCRs which provided the amount of amplified product just below the saturation level, and the estimated copy numbers of HCV RNA in a specimen are shown in Fig.  2A ; the result of a change of copy number in each specimen is shown in Fig. 2B . The HCV level was decreased once during 2 days p.i. and then increased to more than 10 4 at 4 days p.i. This level was maintained for at least 6 days, providing a clear indication that HCV proliferates in MT-2C cells. The 5Ј UTR of positive-stranded HCV RNA in the culture medium could be detected until at least 11 days p.i. The amount of HCV RNA was estimated to be more than 10 4 copies per ml of culture medium (data not shown). 
The 5Ј UTR of positive-stranded RNA was detected by RT-nested PCR. (7). The 5Ј UTR of positive-and negative-stranded HCV RNAs was synthesized by in vitro transcription as a positive standard for semiquantitative analysis of HCV by using the cDNA clones containing sequences from nucleotides 19 to 488 of the 5Ј terminus of the HCV-J genome (14) , which were cloned into the EcoRI site of the pTZ19R vector in the sense and antisense orientations (7) . RNA which had been serially diluted 10 times was amplified by PCR for 35 to 10 cycles as indicated. The products were visualized by staining with ethidium bromide after gel electrophoresis. (B) MT-2C cells (2 ϫ 10 6 ) were infected with serum 1B-1 (10 5 HCV RNA copies) for 24 h. After being washed with PBS three times, the cells were suspended in 1 ml of medium and divided into 10 wells (2 ϫ 10 5 cells per 100-l well). The 5Ј UTR of HCV RNA was amplified by RT-nested PCR with different cycle numbers (from 10 to 35) as shown in Fig. 1A , and the amount of HCV RNA in the original specimens was estimated by determining the highest cycle number of the PCR at which the amplified product was under the saturation level. The open circle indicates HCV RNA titer in cells after 2 days of IFN-␣ (10 2 U/ml) treatment. Amplification of negative-stranded HCV RNA by a complementary sequence for HCV RNA at 3, 8, and 11 days p.i. was conducted. A negative control experiment was conducted by the PCR without a primer.
Detection of negative-stranded HCV RNA would be useful to confirm HCV replication in cells, because negative-stranded HCV RNA is considered a replication intermediate of the viral genome. We first conducted a conventional assay for negativestranded HCV RNA by using sense primer 196 for synthesis of cDNA derived from negative-stranded RNA and using no primer as a control. After inactivation of RT by boiling for 30 min, PCR was performed under conditions for detection of positive-stranded HCV RNA as described above. As shown in Fig. 2B , amplified signals were obtained at 3, 8, and 11 days p.i. with a sense primer, but no signals were detected from the samples for which no primer was used. Negative-stranded HCV RNA was detected in RNA specimens within the first 11 days p.i. (data not shown). However, in this analysis the possibility remains, as pointed out previously (7) , that the signals detected with a sense primer might be produced by the selfpriming of positive-stranded HCV RNA in reverse transcription. To confirm the detection of negative-stranded HCV RNA, we applied two other recently reported strategies with strand specificity (7, 22) . One method, which we developed, uses chemical modification of RNA at the 3Ј end to avoid self-priming activity during cDNA synthesis (7), and the other method is the tagged RT-PCR method using tagged primers to avoid amplification of self-primed cDNA (22) . As shown in Fig. 3 , negative-stranded HCV RNA was detected in the cells at 5 days p.i. by both methods. These results, together with the conventional assay for negative-stranded HCV RNA, demonstrated the presence of intracellular negative-stranded HCV RNA. Thus, we concluded that HCV replicates in the cultured cell line MT-2C.
IFN-␣ and IFN-␤ are used for the clinical treatment of patients with chronic C-type hepatitis. However, only 15 to 35% of patients treated with IFN-␣ show a long-term response (5, 39) . The mode of the anti-HCV effects of IFN is not clear at this time. To address the effect of IFN-␣ on HCV proliferation in MT-2C cells, HCV-infected MT-2C cells at 5 days p.i. were treated with IFN-␣ (Mochida Pharmaceutical Co., Ltd.) at a final concentration of 10 2 U/ml for 2 days. IFN-␣ was not detected in the culture medium of non-HCV-infected MT-2C cells by enzyme-linked immunosorbent assay and was not toxic to MT-2C cells at this concentration. Semiquantitative analysis of HCV RNA revealed that HCV RNA decreased to about 10% 2 days after IFN-␣ treatment (Fig. 2B) .
To investigate whether viral multiplication is affected by conditions of host cell growth, we tested the effects of several antibiotics on HCV RNA replication. Growth inhibition of MT-2C cells was observed in the presence of G418 (0.3 mg/ml), hygromycin B (100 g/ml), puromycin (0.5 g/ml), or blasticidin S (10 g/ml). In the presence of each antibiotic, the cell doubling time extended from 2 days to about 1 week. As shown in Table 2 , the 5Ј UTR of positive-stranded HCV RNA was detected in the cells treated with G418 (0.3 mg/ml) at 35 days p.i. and in the hygromycin B-treated cells (100 g/ml) until 43 days p.i., while HCV RNA was detected until 30 days p.i. in untreated cells (Fig. 1 ). This result indicates that these antibiotics support HCV retention in cells in prolonged culture. The exact mechanism of longevity of HCV RNA in cells treated with G418 is not known. However, prolongation of virus growth and extension of the period of the cell cycle in which HCV RNA can be retained are possible explanations.
Replication and multiplication of various viruses are inhibited by antisense oligonucleotides (3) . Recently, we reported that an antisense oligonucleotide, AC2*-oligo (10 M), complementary to the region containing the initiator AUG codon of the viral core encoding region (Fig. 4A) , inhibited HCV replication in HCV-infected MT-2C cells at 4 days p.i., as determined by the analysis of RT-PCR of the 5Ј UTR (27) and the NS5B region (Fig. 4B) . However, a control oligonucleotide with an inverse orientation relative to that of AC2*-oligo did not show an inhibitory effect (data not shown). When cells were cultured for 7 days after removal of AC2*-oligo, HCV RNA again became detectable at the 5Ј UTR (data not shown) and the NS5B region (Fig. 4B) , suggesting that AC2*-oligo had a specific and reversible inhibitory effect. HCV began replication in the cells after elimination of the antisense oligonucleotide.
HCV was shown to be transmissible from cell to cell (37) . To clarify the mode of viral transmission in our system, we examined the possibility of cell-free viral transmission. After inoculation, HCV-infected MT-2C cells were cultured for 4 days, after which the culture medium was centrifuged at 6,000 rpm (3,500 ϫ g) for 3 min to remove the remaining cells. This process was repeated three times, and the resultant supernatant was frozen at Ϫ80ЊC to destroy any remaining cells. After thawing the supernatant at room temperature, we confirmed the absence of cells in it by microscopic observation. The supernatant was added to fresh uninfected MT-2C cells, which were then maintained for another 8 days. As shown in Fig. 5A , positive-stranded HCV RNA was detected in the cells at 6 and 8 days p.i., even though it was undetectable at 2 days p.i. This result indicates that the cell-free culture medium from HCVinfected MT-2C cells contains infectious virions.
To examine whether other cloned MT-2 cells shed the infectious virus into the culture medium, culture medium obtained 4 days after HCV infection from MT-2A cells, which (7). Chemical modification of RNA samples at the 3Ј end was carried out as described in reference 7. The sense primer 196 was used for cDNA synthesis. After inactivation of RT by boiling for 30 min, cDNA was amplified by the same method to amplify for the 5Ј UTR of positive-stranded HCV RNA as described in the legend to Fig. 1. (B) Tagged RT-PCR method (22) . The tag-381 primer (5Ј-TCATGGTGGCGAATAAGCC ATGGCGTTAGTAT-3Ј, corresponding to positions 70 to 85 of HCV-J [14] ), containing a tag sequence (underlined), was used for synthesis of cDNA. After being boiled for 30 min, cDNA was amplified with the tag primer and 382R (5Ј-CGCGGCAACAGGTAAA-3Ј, corresponding to positions 430 to 445 of HCV-J [14] ). The second PCR was performed with primers Tag A (5Ј-GTGG CGAATAAGCCATGGCG-3Ј) and 197R. To evaluate the amplified products, Southern blot hybridization was performed with a 32 P-labeled probe derived from an internal sequence of the PCR product (4). (Fig. 5B) . However, when the same volume of this culture medium, treated as described above, was used to inoculate other fresh MT-2A cells, intracellular HCV RNA was detected again 3 days p.i., suggesting that infectious HCV, although at levels undetectable by RT-nested PCR, was present in the culture medium (Fig. 5B) . These results suggest that HCV can infect MT-2 cells by the cell-free mode. Although the diameter of the HCV particle has been identified as being between 55 and 65 nm (12) , almost all the infectious HCV present in the culture medium was not filtered through a 0.2-m-pore-size filter (Z-spin; Gelman Science) (data not shown). The HCV particles produced from infected MT-2C cells might have associated with cell components or with other factors in the culture medium without losing infectivity and thus might not have been filtered. Alternatively, the filter membrane might remove HCV from the filtrate by nonspecifically adsorbing the virus.
The reason that the lymphotropic T-cell line MT-2 is highly susceptible to HCV infection is unknown. However, there are several reports which show the presence of negative-stranded HCV RNA in peripheral blood mononuclear cells from patients with chronic hepatitis (4, 7, 28, 31, 32, 42) . Furthermore, two human T-cell lines, Molt4-Ma and HPB-Ma, are susceptible to HCV infection (35) (36) (37) . Recently, it was shown that human peripheral blood mononuclear cells are susceptible to some HCV-positive human sera (4) . Therefore, HCV replication in lymphotropic cells might reflect the natural viral replication in patients with chronic hepatitis, although there is a report denying the replication of HCV in human peripheral blood mononuclear cells (21) . The MT-2 cell line was established by HTLV-1, which immortalizes normal lymphocytes upon infection. A recent epidemiological study correlated the presence of anti-HCV antibodies with serological HTLV-1-positive status, suggesting high susceptibility for HCV infection among HTLV-1 carriers (13). In addition, an increased prevalence of HTLV-1 infection in Japanese patients with hepatocellular carcinoma has been reported (30) . HTLV-1 infection in lymphocytes likely creates a supportive environment for HCV replication.
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